In March 2025, the company declared new plans for any direct-to-consumer featuring of its Wegovy weight loss drug. The company established a completely new pharmacy, called NovoCare, which might demand customers $499 per 30 days for entry to the drug, under 50 percent the price of the drug as a result of other pharmaceutical distribution networks.[